Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
v7 (2 trials)
v-5 immunitor (1 trial)
Tuberculosis (Phase 3)
Trials (3 total)
Trial APIs (2 total)